Cytomegalovirus infection after liver transplantation incidence, risks, and benefits of prophylaxis

Cytomegalovirus (CMV) infection and related disease is a feared complication after liver transplantation. Antiviral prophylaxis is recommended in clinical practice guidelines depending on the CMV status of both donor and recipient as well as the individual risk profile.

Saved in:
Bibliographic Details
Main Authors: Weigand, Kilian (Author) , Schnitzler, Paul (Author) , Schmidt, Jan (Author) , Chahoud, Fadi (Author) , Gotthardt, Daniel (Author) , Schemmer, Peter (Author) , Stremmel, Wolfgang (Author) , Sauer, Peter (Author)
Format: Article (Journal)
Language:English
Published: 9 September 2010
In: Transplantation proceedings
Year: 2010, Volume: 42, Issue: 7, Pages: 2634-2641
ISSN:1873-2623
DOI:10.1016/j.transproceed.2010.04.025
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.transproceed.2010.04.025
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0041134510008857
Get full text
Author Notes:K. Weigand, P. Schnitzler, J. Schmidt, F. Chahoud, D. Gotthardt, P. Schemmer, W. Stremmel, and P. Sauer
Description
Summary:Cytomegalovirus (CMV) infection and related disease is a feared complication after liver transplantation. Antiviral prophylaxis is recommended in clinical practice guidelines depending on the CMV status of both donor and recipient as well as the individual risk profile.
Item Description:Gesehen am 18.10.2023
Physical Description:Online Resource
ISSN:1873-2623
DOI:10.1016/j.transproceed.2010.04.025